Home >Information for Physicians >More Information About the VCRCs

Information for Patients

More Information About the VCRC...

The Vasculitis Clinical Research Consortium (VCRC) is an integrated group of academic medical centers, patient support organizations, and clinical research resources dedicated to conducting clinical research in different forms of vasculitis and improving the care of patients with vasculitis. Funded by the National Institutes of Health (NIH), the VCRC is part of the Rare Diseases Clinical Research Network. The operations of the VCRC are directed from Boston University and the four Primary VCRC Study Sites include Boston University School of Medicine, the Cleveland Clinic Foundation, Johns Hopkins University School of Medicine, and the Mayo Clinic.

The VCRC will establish a large longitudinal cohort of patients with the six VCRC diseases: Wegener’s Granulomatosis, Microscopic Polyangiitis, Churg Strauss Vasculitis, Polyarteritis Nodosa, Takayasu’s Arteritis, and Giant Cell Arteritis. Among the four primary VCRC Centers, approximately 1,000 patients will be followed in the cohort. It is expected that other sites, both in the U.S. and internationally, will eventually be participating in the cohort studies as well. A comprehensive set of clinical radiographic and laboratory data will be collected on patients in the VCRC longitudinal studies as well as biological specimens. Utilizing the cohort data, we will conduct projects to discover new biomarkers for vasculitis disease activity and prognosis, develop and standardize outcome measures for the different types of vasculitis, and develop and standardize imaging techniques for the large vessel vasculitides. We will also conduct clinical trials of promising new therapeutic agents. Patients need not be enrolled in all studies to participate in VCRC activities.

Although each of the VCRC Centers are expert centers for the evaluation and management of patients with vasculitis, the goal of the VCRC is not to provide care, but to conduct research. However, it is anticipated that patients and physicians will wish to refer patients for the dual purpose of clinical evaluation and potential research participation, and the VCRC Investigators welcome such interaction.

VCRC Investigators are extremely excited about the potential for the VCRC to become the focal point of patient-oriented clinical investigation in vasculitis for many years. The generous support of the NIH has provided us with the resources necessary to create this ongoing clinical research infrastructure.

Also see: Goals of the VCRC

 
Join the VCRC Contact Registry